TSX:APTXPharmaceuticals
Apotex Health (TSX:APTX) Stock Could Be 51.7% Below Fair Value After Its IPO
IPO, early trading moves and why Apotex Health is suddenly in focus
Apotex Health (TSX:APTX) has quickly drawn investor attention after completing a roughly CA$1.5b IPO at CA$24 per share, with early trading marked by share price swings and debate over what the new listing is worth.
The offering combined a treasury sale of new shares with a secondary sale by existing holders. This structure put fresh capital on the company’s balance sheet while giving SK Capital Partners and other...